Latest Insider Transactions at In8 Bio, Inc. (INAB)
This section provides a real-time view of insider transactions for In8 Bio, Inc. (INAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IN8BIO, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IN8BIO, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2021
|
Emily Fairbairn |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.92%
|
$1,000,000
$10.0 P/Share
|
|
Aug 03
2021
|
Emily Fairbairn |
BUY
Conversion of derivative security
|
Indirect |
3,333,315
+49.22%
|
-
|
|
Aug 03
2021
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,625,102
+50.0%
|
-
|
|
Aug 03
2021
|
William Tai Wei Ho PRESIDENT AND CEO |
BUY
Conversion of derivative security
|
Indirect |
3,070
+4.04%
|
-
|
|
Aug 03
2021
|
Leslie W. Kreis > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,625,102
+50.0%
|
-
|